which the cystic fibrosis (CF) gene has been disrupted so that no CFTR is produced) murine tracheas could be distinguished. The difference between the current elicited by forskolin in wild-type and CF tracheas was highly significantly different (P < O OO1), giving a CFTRdependent current of 11 2 ,uA cm2. 5. Transfection of the airways with pTriallO-CFTR2, but not pTriallO, significantly (P <O0O1) increased the CFTR-dependent chloride secretory current in CF tracheas. The degree of correction was greater when intra-tracheal installation rather than nasal insufflation was used to deliver the plasmids.
Cystic fibrosis (CF) is a monogenic autosomal recessive disorder. The CF gene encodes an epithelial chloride channel (the cystic fibrosis transmembrane conductance regulator, CFTR) which is located in the apical membranes of many epithelial cell types and is activated by cAMP-dependent protein kinase A and ATP. A loss of activity of this channel in the airways of CF patients is the major cause of morbidity and premature mortality (Riordan et al. 1989; . The physiological relevance of this study is to explore how the human disease is reflected in the behaviour of an airway epithelium from transgenic mice and to discover a method to dissect the CFTR-dependent component of the chloride secretory response from CFTR-independent ones.
There is now considerable effort being invested in the development of gene therapy for the pulmonary aspects of cystic fibrosis (Wilson, 1995) . Two types of gene delivery vector have received most attention. Adenoviral vectors are tropic for the airway epithelium and can, potentially, deliver the CF gene with high efficiency. However, single and repeated application of adenoviral vectors in animals and 1 1 To whom correspondence should be addressed.
humans generates an unacceptable immunological and inflammatory response (Marshall, 1995) . An alternative approach is to use cationic liposomes to deliver the CFTR cDNA to the airway epithelia (Caplen et al. 1995) . no CFTR is expressed and epithelial cells fail to show cAMPdependent increases in chloride permeability. We have previously shown that the delivery of the CFTR cDNA as a plasmid pREP8-CFTR complexed with cationic liposomes to CF-null mice restores chloride secretion in the trachea in response to forskolin, an activator of adenylate cyclase (Hyde et al. 1993) . However, in that study only young animals (< 10 g) could be used as an alternative chloride conductance develops in older animals, both in CF null and AF508 CF mice . In older animals chloride secretion in the mouse trachea results from both cAMP-mediated and calcium-mediated processes. As forskolin also increases intracellular calcium in the airways, the secretory response is composed of both components, only part of which is CFTR mediated (Grubb, Paradiso & Boucher, 1994 
METHODS
Construction of pTriallO and pTriallO-CFTR2 Plasmid pTrial4 consists of base pairs (bp) 1-2446 of pAT153 (Twigg & Sherratt, 1980) (Riordan et al. 1989 ) was introduced into the unique PvuII-XhoI sites of pTriallO to create pTriallO-CFTR2. The cDNA incorporated two minor changes from the published sequence, T to C at nucleotide 936 ) and A to C at nucleotide 1990 ) and included a Kozak translation initiation sequence (Kozak, 1986) immediately 5' to the translation initiation codon. The entire nucleotide sequence of pTriallO-CFTR2 was confirmed prior to use and its structure is given in diagrammatic form in Fig. 1 .
Plasmid pTrial4 and its derivatives were propagated in E. coli NSURE, a tetracycline-sensitive derivative of E. coli SURE (Stratagene, Cambridge, UK), in growth media supplemented with 10 jug ml' of tetracycline and purified using Qiagen-tip 2500 MEGA columns (Qiagen, Hilden, Germany) for the cellular studies. For the mouse work the plasmid was purified by the standard alkaline lysis method followed by CsCl density gradient purification.
Liposomes
Cationic liposomes were formulated from 3,B (N-(N'JV-dimethylaminoethane)-carbamoyl) cholesterol (DC-Chol) and dioleoyl phosphatidylethanolamine (DOPE). DC-Chol-DOPE in a 6:4 molar ratio was prepared by microfluidization at a final concentration of 2 ,umol ml-' in water, equivalent to 1-2 mg ml-' of total lipid (Gao &Huang, 1991 Cheng et al. (1990) . The anti-CFTR antibody used was AIATG1 104 (a kind gift from Transgene, France) raised against the R-domain of CFTR. y-32P-labelled immune precipitates were electrophoresed on a 75 % polyacrylamide gel and CFTR visualized by autoradiography. SPQ fluorescence measurements HEK 293 cells were transfected with plasmids pTriallO and pTriallO-CFTR2 as above, except that the cells were cultured on glass coverslips. The cells were then loaded with the halide-sensitive fluorophore 6-methoxy-A-(3-sulphopropyl)-quinolinium (SPQ) by hypotonic shock in Nal buffer for 20 min, and allowed to recover in isotonic Nal buffer (Chao, Dix, Sellars & Verkman, 1989) . The cells were assayed for the presence of cAMP-activated halide efflux as described by Rich, Gregory, Anderson, Manavalan, Smith & Welsh (1991) . Fluorescence was detected every 30 s using a Leica DAMIRBE fluorescence microscope (Leica, UK) in conjunction with an Improvision intracellular ion-imaging system (Improvision, UK). Excitation was at 350 nm and emission was collected at 420 nm and above. Fields of cells (typically 25-100 cells) were visualized at x 200 magnification. To quench SPQ fluorescence, cells were initially incubated in a buffer containing Nal. After 120 s of control recording, the bathing medium was changed to a buffer containing NaNO3. After a further 300 s the bathing medium was changed to NaNO3 buffer containing 100 /uM 3-isobutyl-l-methyl- contains a mutation of the ATG initiation codon to GTG at posit 89 as described in AIethods.
Transfection of CF-null mice CF-null mice anaesthetized writh Avertin (Bromethol, Bayer Products Ltd) given intraperitoneally (0-02 ml (g body wt)-') were transfected using cationic liposomes complexed with plasmids pTriallO-CFTR2 or pTrialO either intra-tracheally or intra-nasally. The transfecting agents were prepared by mixing 10 jug of plasmid DNA with 100 nmol of DC-Chol-DOPE and diluted to a volume of 100 #u1 in Krebs-Hepes buffer (mM): NaCl, 140; KCl, 6; A9gCl2, 1; CaCl2, 2; glucose, 10; and Hepes, 10; pH 9.
A 100 ,ul aliquot of the formulation was delivered into the trachea through a blunt-ended steel tube attached to a syringe in 20 jul aliquots over a 30 min period. Animals were allowed to recover from the anaesthetic, returned to their cages and used 2 days later. The procedure for nasal transfection was similar except that the liposomes were diluted in water. Small volumes, 2 #sl, were placed in turn on each nostril and were drawn into the airways as the animal breathed, until 100 /Ll had been administered. The animals were used 2 days after the transfection had taken place. Measurement of short circuit current (SCC) in murine tracheal epithelium
WVild-type and CF-null mice were killed by exposure to a rising concentration of CO2 and the trachea and colon quickly removed and placed into fresh, cold Krebs-Henseleit Solution (KHS). The trachea was opened below the larynx by cutting through the centre of the cartilaginous rings. Only one preparation was obtained from each mouse and a piece about 2 mm square was fashioned from the opened tube. This was mounted in an UJssing chamber with a window area of 2-3 mm2. The tissue was continually short circuited using a WPI dual voltage clamp with series resistance voltage compensation. Each side of the tissue was bathed in KHS, kept at 37°C, and bubbled with 95 % 02-5% CO2. SCC was recorded either on a pen recorder or the data were collected and stored using a AMacLab in conjunction with an Apple Alacintoslh Computer. Drugs could be added to either the apical or basolateral side of the tissue by adding them to the reservoirs from which the warmed KHS was circulated. As the tissue window was at the cone-shaped end of each half-chamber the diffusion of drugs into this less well-stirred space was sometimes slow. To overcome this problem, the bath solution was bled from the voltage-sensing electrodes. These consisted of fine polythene tubes filled with KHS which led via a 3 M KCl-agar plug to a 3 M KCl solution containing a calomel cell. As the ends of the voltage-sensing electrodes were closely apposed to the tissue, bleeding for a few seconds drew the bulk bath solution into the tissue region.
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Colonic epithelia (20 mmll2) were mountecl in Ussing clhambers as described previously (Cuthbert et at. 1994) . The KHS had the following composition (mm): NaCl, 118; KCl, 4-7; CaCl2, 2-5; MgSO4, 1-2; KH2PO4, 12; NaHC03, 25-0; and glucose, 11i. The solution was bubbled with 95 % 02-5% CO2 and had a pH of 7-4 at 37 'C. Experimental criteria for the inclusion of data from tracheas \While the tracheal preparations wsere stabilizing, amiloride (100 um) andl forskolin (10 UmI) wvere applied to the colons from the same mouse followed bAy frusemiide (furoseinide; 1 mM). In CF colons, forskolin causes a decrease in SCC due to potassium secretion which is reversed by frusemicle (Cuthbert et al. 1994 ). This procedure was used as an internal control for the genotype determined wvith the polymerase chain reaction and Southern blotting, but no furtlher use was made of the colonic tissues. Each tracheal epithelium was exposed in turn to a mixture of TBHQ (25 tzm) and A231.87 (1 #I) on both sides, then forskolin (10 LM) on both sides, and finally frusemide (1 mM) on the basolateral side. Amiloride (100 um) was added apically either at the beginning of the experiment or after the response to TBHQ-A23187 had been established. If the SCC response to TBHQ-A23187 failed to increase by more than 15 1sA cm2 (approximately 1 in 5 of all mice) the tissue was abandoned. Peak responses to TBHQ-A23187 could reach 70 #zA cm-2 and when they were less than 15 #tA cm-2 it was unsafe to assume that the calcium stores had been discharged. For tracheas meeting the inclusion criterion the response to TBHQ-A23187 was recorded both at the peak SCC and again after 30 min when forskolin was added followed by frusemide (see Fig. 6 ). In this study forty-three mice (9 wild-type, 34 CF) met the above inclusion criteria but a further four were eliminated from the analysis. All four were from the groups receiving transfection by intra-tracheal instillation of pTriallO or pTriallO-CFTR2 and showed unusual behaviour, basal SCCs were 3-4 times greater than normal, responses to TBHQ-A23187 did not decay with time and the responses to forskolin were greater than the group mean by 8-20 times the S.D., clearly representing another population. We suspect that tracheal damage, either during transfection or mounting, was responsible. Statistical treatment of data Student's t test was used to compare different sets of data and P < 0 05 was taken to indicate a significant difference. , age (days; 1) and basal SCC (,uA cm2; *) for tracheas from the 6 groups of mice used in the study. Means + S.E.M. are given. The number of animals in each group (n) were as follows: wt (wild-type untreated), n = 9; cf (CF-null untreated), n = 7; CFTR (CF-null tracheally lipofected with pTriallO-CFTR2), n = 5; pT (CF-null tracheally lipofected with pTriallO), n = 6; nCFTR (CF-null nasally lipofected with pTriallO-CFTR2), n = 6; and nT (CF-null nasally lipofected with pTriallO), n = 6. Basal SCC was significantly less in the cf group compared with the wt group (P < 0 05). Basal SCCs in the treated groups were not sigificantly difFerent from either the wt or cf values. The increase in SCC caused by TBHQ-A23187 applied at time zel (a) and the SCC increase remaining after a further 30 min (U). TI numbers and codings in each of the 6 groups are as in Fig. 1 The CF mice were allotted to one of five groups while wildtype mice formed a sixth group. The groups, of size n, were designated as follows: (a) wild-type untreated (wt), n = 9; (b) CF-null untreated (cf), n = 7; (c) CF-null treated by tracheal instillation of pTriallO-CFTR2 (CFTR), n = 5; (d) CF-null treated by tracheal instillation of pTriallO (pT), n = 6; (e) CF-null treated by nasal instillation of pTriallO-CFTR2 (nCFTR), n= 6; and (f) CF-null treated by nasal instillation of pTriallO (nT), n = 6. Figure 3 shows the weights, ages and baseline SCC values of the six groups. All animals were in the age range of 25-89 days with a mean age of 43-3 + 2-3 days. All groups had a mean age close to this value except pT, which were younger with the ages closely clustered. All the CF groups (b-f) had mean weights less than those of the wild-type group. This is expected since CF mice fail to thrive as well as wild-type and achieve lower weights at a comparable age. Basal SCC was significantly lower (P < 005) in the untreated null animals than in the wild-type group, while the other CF groups all had basal SCC values similar to those of wild- type. All the groups (c-f) had been treated in some way, whereas groups (a) and (b) were untreated. Figure 4 shows the combined effect of TBHQ and A23187 on SCC in the six groups of tracheas. All groups achieved a mean initial peak value close to 30 ,uA cm-2, which was twice the exclusion value (15 gA cm-2), the level at which tissues were abandoned. Over a period of 30 min in the presence of the calcium mobilizing agents, the SCC fell to about 12 ,uA cm-2 above baseline, except the pT group where the current was more maintained. There was no obvious reason for this difference. Amiloride and cAMP mediated responses in wild-type and CF tracheal epithelia. Figure 5 gives the changes in SCC caused by amiloride and forskolin in the six groups of murine tracheas. The response in the cf group to amiloride was significantly less than in the wt group (3 5 + 1P5 versus 9.9 + 15 uA cm-2, means + S.E.M., P < 0 05). However, basal SCC was also less in the cf group compared with wt (13-0 + 3-6 versus 27-1 + 35 ,uA cm-2, means + S.E.M., P < 0-05; Fig. 3 Combining the data for all mice transfected with pTriallO-CFTR2 by either route (all lipo, n = 11) with those transfected with pTriallO (all mock, n = 12), there was a significant difference with a higher probability than with the tracheally transfected group alone (8-7 + 1 1 ,uA cm2 compared with 4-5 + 0 7 ,uA cm2, P < 0 01). All the data from the transfection studies are given in Fig. 5 . At the end of each experiment frusemide (1 mM) was added to inhibit chloride secretion by inhibiting the Na+-K+-2Cl-cotransporter, but complete inhibition of SCC was not seen in any group, either because chloride ions can enter the cells by other than on the cotransporter or other unidentified currents were present. However, there was no significant difference between the degree of frusemide inhibition of SCC in any of the groups, which were as follows: wt, 57 0 + 5 7%; cf, 63f3 + 15f9%; CFTR, 67f2 + 6f4%; pT, 45*3 + 11f9%; nCFTR, 76-0 + 9-8; and nT, 44-2 + 13-2%.
RESULTS

Expression
Traces typical of the SCC records from individual experiments are given in Fig. 6 where the effects of TBHQ-A23187, amiloride, forskolin and frusemide are shown.
Other approaches used to dissect components of the chloride secretory response. Initial attempts to deplete the calcium stores were made with thapsigargin. Like TBHQ, thapsigargin increased SCC after which responses to forskolin could be obtained in wild-type tracheas. However, thapsigargin proved to be extremely difficult to remove from the walls of the apparatus so there were apparent effects on current in subsequent experiments before agents were added. Consequently TBHQ was used in preference to thapsigargin. An alternative strategy was to use BAPTA to chelate calcium ions intracellularly. However it was not possible to differentiate between calcium-independent responses, and responses in which the intracellular buffer had become saturated so revealing a calcium-dependent current.
A further alternative was to use a blocking agent of calciumsensitive chloride channels, and 4,4'diisothiocyanate-stilbene-2,2'-disulphonic acid (DIDS) has been reported to have this effect (Clarke, Grubb, Yankaskas, Cotton, McKenzie & Boucher, 1994) . mice only the calcium component of the forskolin response should be present which will, theoretically, be blocked by DIDS. It is seen in Fig. 7 that the responses in the presence of DIDS were considerably larger than after treatment with TBHQ-A23187, especially for CF-null tracheas (17-4 + 1.0 versus 2-5 + 0-6 uA cm-, P < 0001). Thus it was not possible to use this method to differentiate wild-type and CF tracheas.
DISCUSSION
The ion-transporting activity of airway epithelia has many components, including CFTR-dependent and -independent chloride secretory activity together with electrogenic sodium absorption. Methods have been developed to dissect these components in the tracheal epithelium of the mouse, both wild-type and a transgenic animal with a CF-null mutation. CF not only eliminates the possibility of one component of chloride secretion but other transporting activities show adaptations to the absence of CFTR. We have investigated these and explored the possibility of restoring normal physiological function by transfection using a new plasmid complexed with cationic lipids. The basal transporting activity (SCC) of the tracheal epithelium in the six groups were not different except for the cf group, where the amiloride-sensitive current was significantly (P < 005) less than in the wt group, indicating that in CF animals the tracheas are hypo-absorbing sodium, a feature we have previously reported for CF-null and AF508 CF animals (Hyde et al. 1993; Colledge et al. 1995) , while nasal epithelia show an enhanced amiloride-sensitive sodium current (Grubb, Vick & Boucher, 1994) . We have not shown here that transfection with CFTR restores the wild-type level of sodium absorption, even though responses in the treated animals were not different from the wild-type, as this occurs even when treatment was with pTriallO. In this study one aim was to establish a reliable test to determine phenotype using the mouse trachea. Cultured airway epithelia derived from the nasal passages or the trachea of CF mice fail to respond to forskolin, yet do respond to the calcium ionophore, ionomycin, the latter effect being blocked by DIDS. It is concluded from these earlier studies that CF cells have a Ca2P-regulated Clconductance (Clarke, Grubb, Gabriel, Smithies, Koller & Boucher, 1992; Clarke et al. 1994) . However, the situation in fresh, intact epithelium from the trachea is different from the properties of cultured tracheal epithelia. First, only in tracheas from young mice is there a detectable difference in the chloride secretory responses to forskolin between wildtype and CF animals (Hyde et al. 1993; Colledge et al. 1995) .
Further, forskolin increases intracellular calcium (Ca!+) in freshly isolated cells from both CF and wild-type tracheas, the response disappearing if the cells are cultured for a few days (McCann, Bhalla & Welsh, 1989; (Burgess, Bird, Obie & Putney, 1991) . For this reason it was considered important to use a Ca2+-ATPase inhibitor to empty intracellular stores. Originally, thapsigargin was chosen because of proven effects on epithelia (Brayden, Hanley, Thastrup & Cuthbert, 1989) but because of difficulties with adhesion to the chambers an alternative, TBHQ, was used. This agent has been shown to be as equally effective as thapsigargin (Oldershaw & Taylor, 1990) and to act on epithelia (Chao et together produced a large increase in current which declined slowly over 30 min, at which time forskolin was added. Under these conditions and in the presence of amiloride, the responses of wild-type and CF tracheas to forskolin were easily differentiated. CF tracheas still maintained a small response (ca 25 ,uA cm-2), but the origins of this current remain unknown. Two other attempts to eliminate the effects of forskolin-released calcium were not successful.
When using DIDS to block Ca2P-sensitive chloride channels in CF tracheas the responses to forskolin were significantly (P < 0001) greater than those obtained using the TBHQ-A23187 protocol. Thus DIDS is not a sufficiently specific or active antagonist to be useful. Similarly we rejected the use of the Ca2+ chelator BAPTA, because while it reduced the responses to forskolin there was no way to differentiate whether the residual responses were CFTR mediated or the capacity of the chelator to bind Ca2P was saturated. By instilling liposomes in the trachea it was possible to increase significantly the response to forskolin in CF tracheas with pTriallO-CFTR2 into the wild-type range. When pTriall O-CFTR2 liposomes were instilled nasally, the forskolin-sensitive current of the trachea was significantly greater than that of CF-null tracheas (P < 005), although not significantly greater compared with those of CF mice receiving pTriallO. However, comparing tracheas from all lipofected animals with those from animals receiving mock transfection showed there was a significant (P < 0 01) increase in the response to forskolin. When the data are presented as a scatter diagram (Fig. 8) it can be seen that nine of the eleven CF mice receiving pTriallO-CFTR2 had cAMP-sensitive chloride currents in the normal range. The plasmid used in this study was specifically designed for use in a clinical trial to be delivered complexed with cationic lipsomes to the nasal epithelium of CF patients. In an earlier study (Hyde et al. 1993 ) plasmid pREP8-CFTR, containing the ampicillin-resistant gene, was used. It is a formal possibility that such a plasmid could be transmitted to resident airway bacteria and could lead to low-level resistance to fl-lactam antibiotics. Plasmid pTriallO-CFTR2 encodes a gene for resistance to tetracycline, an antibiotic unlikely to be used as a treatment for lung infections, It is known that expression of bacterial genes can raise an immune response in animal models (Bronte et al. 1995) . In the present study, several steps were taken to limit the possible expression of the tetracycline-resistant gene in human airway cells during a clinical trial. These included the subcloning of the bacterial gene in the opposite direction to the CFTR gene and the screening of the sequence to avoid inclusion of potential eukaryotic expression signals. As a cycline-resistant gene was changed to GTG. Whereas bacterial ribosomes are able to initiate at both AUG and GUG, eukaryotic ribosomes initiate exclusively at AUG codons (Stewart, Sherman, Shipman & Jackson, 1971; Sherman, McKnight & Stewart, 1980) . For example, a mutation in the CFTR gene in which the initiation codon is changed from ATG to GTG has been identified in three CF patients (Cheadle, Belloni, Ferrari, Millar-Jones & Meredith, 1994) . The DC-Chol-DOPE liposomes used in this study are approved for human use and have been used in several genetherapy clinical studies (Nabel et al. 1993; Caplen et al. 1995 Geddes, 1994) . The greatest drawback with the liposome approach is the low efficiency of delivery. Apparently it is only necessary to transfect 5% of cells to restore the CFTR-dependent chloride conductance in xenografts (Goldman, Yang & Wilson, 1995) , yet in human CF airways there is not only a failure of cAMP-dependent chloride conductance but also an increase in electrogenic sodium absorption. The latter contributes substantially to the dehydration of mucus, perhaps more so than the failure of chloride secretion. When CFTR chloride channels are co-expressed with amiloride-sensitive sodium channels the sodium conductance is limited compared with that found when expressed alone (Stutts et al. 1995) . Thus CFTR channels regulate sodium channels by an unknown mechanism which apparently influences mean open time (Disser & Fromter, 1989) . Thus while transfection of 5% of airway cells restores chloride conductance this level of transfection has no effect on sodium transport (Goldman et al. 1995) . Therefore CFTR expression will need to be greater than 5 % of normal to affect clinical improvement, although restoration of cAMP-sensitive chloride conductance is achieved at low expression levels. In conclusion the method we have evolved here does allow the CFTR-dependent component of the tracheal response to be determined without interference from the calciumdependent component, making the CF-null trachea a useful tissue in which to investigate gene therapy in vivo. Finally, if the fraction of responding animals could be reproduced in man, and if repeated doses produce no untoward effects, a small step towards clinical treatment will have been made. The report of a successful clinical trial with pTriallO-CFTR2 will be published elsewhere. further precaution, the ATG initiation codon of the tetra-
